missing translation for 'onlineSavingsMsg'
Learn More
Learn More
CaMKII alpha/beta, p Thr286, p Thr287 Antibody (22B1), Novus Biologicals™
Mouse Monoclonal Antibody has been used in 4 publications
Brand: Novus Biologicals NB110-96869-0.025mg
This item is not returnable.
View return policy
Description
CaMKII alpha/beta Monoclonal specifically detects CaMKII alpha/beta in Human, Mouse, Rat samples. It is validated for Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Paraffin, Immunoblotting.
Specifications
| CaMKII alpha/beta (p Thr286, p Thr287) | |
| Monoclonal | |
| 1 mg/mL | |
| Western Blot 1 μg/mL, ELISA 1:100-1:2000, Immunohistochemistry 1:10-1:500, Immunocytochemistry/Immunofluorescence 1:10-1:500, Immunoprecipitation 1:10-1:500, Immunohistochemistry-Paraffin 1:10-1:500, Immunoblotting | |
| calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha, calcium/calmodulin-dependent protein kinase II alpha, calcium/calmodulin-dependent protein kinase II alpha-B subunit, CaM kinase II alpha subunit, CaM kinase II subunit alpha, CAMKAcalcium/calmodulin-dependent protein kinase type II subunit alpha, CaMK-II alpha subunit, CaMK-II subunit alpha, CaMKIINalpha, CaM-kinase II alpha chain, EC 2.7.11, EC 2.7.11.17, KIAA0968calcium/calmodulin-dependent protein kinase type II alpha chain | |
| Mouse | |
| Protein G purified | |
| RUO | |
| Primary | |
| This antibody is specific for a and B subunits of CaMKII only when they are phosphorylated at Thr-286/287 (in B). | |
| Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. | |
| IgG1 |
| Western Blot | |
| 22B1 | |
| Unconjugated | |
| P11275 | |
| CAMK2A | |
| Synthetic peptide | |
| 0.025 mg | |
| Phospho Specific, Wnt Signaling Pathway | |
| 815 | |
| Human | |
| Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction